
99.71%
Purity
Passed full QC panel
- Variant
- AOD-9604 5mg
- Lot
- AO1001
- Net Peptide Content
- 3.66 mg
- Endotoxin
- Passed
- Heavy Metals
- Passed
- Lab
- Freedom Diagnostics

Please confirm you are 21 years of age or older to enter.
By entering, you confirm that you are 21 years of age or older.
Valence Labs Research
hGH-Fragment Research Peptide
AOD-9604 is a modified C-terminal fragment of human growth hormone. Literature describes it as based on the hGH 177–191 region with an additional N-terminal tyrosine.
Research interest includes metabolic and lipid-signaling biology. Experimental and animal models have examined beta-adrenergic and lipolytic pathway questions. Those preclinical findings should not be turned into consumer weight-loss claims.
AOD-9604 is studied as a modified C-terminal fragment of human growth hormone in laboratory research, including in vitro metabolism work.
Published experimental work has examined metabolic and lipid-signaling questions associated with this hGH fragment.
Animal studies have examined lipid-metabolism questions, including work in obese mice and beta(3)-adrenergic-receptor knock-out mice. Those findings remain preclinical.
AOD-9604 has been examined in in vitro and animal models. Findings from mice or other experimental systems should not be interpreted as established human weight-loss or body-fat outcomes.
This page summarizes published research contexts and does not provide treatment, dosing, or consumer-use guidance.
Catalog details for this product.

99.71%
Purity
Passed full QC panel
Drug testing and analysis
Hormone research
Endocrinology
AOD-9604
5mg